nach oben

Urolithiasis

Erschienen in:

01.12.2023 | Research

The altered composition of gut microbiota and biochemical features as well as dietary patterns in a southern Chinese population with recurrent renal calcium oxalate stones

verfasst von: Cheng Cao, Xiaohua Jin, Qi Ding, Jin Zhu, Dongrong Yang, Bo Fan

Erschienen in: Urolithiasis | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

The correlation among gut microbiota, biochemical features, and dietary patterns in recurrent stone formers has been inadequately investigated in the Chinese population. Forty-two patients with calcium oxalate stones (CaOxS group), including 34 recurrent stone formers (RS group), and 40 nonstone healthy subjects (NS group) from Changshu Hospital Affiliated with Soochow University, were prospectively recruited. Food frequency questionnaires were completed by participants, fasting vein blood was extracted, 24-h urine was collected for biochemical detection, and fecal samples were gathered for 16S ribosomal RNA (rRNA) gene sequencing. BMI; serum levels of triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), magnesium, and creatinine; and urine levels of magnesium in stone formers were significantly different from those of controls, and RS patients showed significantly low serum phosphate and high urine phosphate levels. Celery, bamboo shoots, and pickled food were the favored foods of local stone formers. Patients with recurrent stones had altered microbiota composition, with Escherichia, Fusobacterium, and Epulopiscium being the predominant pathogenic genera. The gut microbiota in RS patients had stronger functions in fatty acid and amino acid degradation but weaker functions in their biosynthesis. The pathogenic genera were positively correlated with BMI; serum levels of TGs and creatinine; urine levels of calcium, phosphate, and uric acid (UA); and celery, bamboo shoots, and pickled food intake. The abundance of Escherichia and Fusobacterium and the levels of serum magnesium and creatinine were the most relevant factors associated with stone recurrence and could be validated as biomarkers of recurrence. Our research provides a novel prevention strategy for the recurrence of renal calcium oxalate stones in the Han Chinese population of southern China.

Nur mit Berechtigung zugänglich

Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan YJWjou (2017) Epidemiology of stone disease across the world. World J Urol 35(9):1301–1320. https://doi.org/10.1007/s00345-017-2008-6CrossRefPubMed

Wang W, Fan J, Huang G, Li J, Zhu X, Tian Y et al (2017) Prevalence of kidney stones in mainland China: a systematic review. Sci Rep 7:41630. https://doi.org/10.1038/srep41630CrossRefPubMedPubMedCentral

Zeng G, Mai Z, Xia S, Wang Z, Zhang K, Wang L et al (2017) Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJU Int 120(1):109–116. https://doi.org/10.1111/bju.13828CrossRefPubMed

Ye Z, Zeng G, Yang H, Li J, Tang K, Wang G et al (2020) The status and characteristics of urinary stone composition in China. BJU Int 125(6):801–809. https://doi.org/10.1111/bju.14765CrossRefPubMed

Vaughan L, Enders F, Lieske J, Pais V, Rivera M, Mehta R et al (2019) Predictors of symptomatic kidney stone recurrence after the first and subsequent episodes. Mayo Clin Proc 94(2):202–210. https://doi.org/10.1016/j.mayocp.2018.09.016CrossRefPubMed

Zhuo D, Li M, Cheng L, Zhang J, Huang H, Yao YJMsmimjoe et al (2019) A study of diet and lifestyle and the risk of urolithiasis in 1519 patients in southern China. Med Sci Monit 25:4217–4224. https://doi.org/10.12659/msm.916703CrossRefPubMedPubMedCentral

Zhao A, Dai M, Chen Y, Chang H, Liu A, Wang PJA-Pjoph (2015) Risk factors associated with nephrolithiasis: a case-control study in China. Asia Pac J Public Health 27(2):NP414-424. https://doi.org/10.1177/1010539512445189CrossRefPubMed

Ding Q, Ouyang J, Fan B, Cao C, Fan Z, Ding L et al (2019) Association between dyslipidemia and nephrolithiasis risk in a chinese population. Urol Int 103(2):156–165. https://doi.org/10.1159/000496208CrossRefPubMed

Gomaa EJAvL (2020) Human gut microbiota/microbiome in health and diseases: a review. Antonie Van Leeuwenhoek 113(12):2019–2040. https://doi.org/10.1007/s10482-020-01474-7CrossRefPubMed

10.

Adak A, Khan MJC, mls CMLS (2019) An insight into gut microbiota and its functionalities. Cell Mol Life Sci 76(3):473–493. https://doi.org/10.1007/s00018-018-2943-4CrossRefPubMed

11.

Loganathan T, Priya Doss CGJLs (2022) The influence of machine learning technologies in gut microbiome research and cancer studies—a review. Life Sci 311(Pt A):121118. https://doi.org/10.1016/j.lfs.2022.121118CrossRefPubMed

12.

Fernandes M, Aggarwal P, Costa R, Cole A, Trinchieri GJNrC (2022) Targeting the gut microbiota for cancer therapy. Nat Rev Cancer 22(12):703–722. https://doi.org/10.1038/s41568-022-00513-xCrossRefPubMed

13.

Bostanghadiri N, Ziaeefar P, Sameni F, Mahmoudi M, Hashemi A, Darban-Sarokhalil D (2021) The controversial association of gut and urinary microbiota with kidney stone formation. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2021.105257CrossRefPubMed

14.

Stern J, Moazami S, Qiu Y, Kurland I, Chen Z, Agalliu I et al (2016) Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers. Urolithiasis 44(5):399–407. https://doi.org/10.1007/s00240-016-0882-9CrossRefPubMedPubMedCentral

15.

Liu Y, Jin X, Hong HG, Xiang L, Jiang Q, Ma Y et al (2020) The relationship between gut microbiota and short chain fatty acids in the renal calcium oxalate stones disease. FASEB J 34(8):11200–11214. https://doi.org/10.1096/fj.202000786RCrossRefPubMed

16.

Nallu A, Sharma S, Ramezani A, Muralidharan J, Raj D (2017) Gut microbiome in chronic kidney disease: challenges and opportunities. Transl Res 179:24–37. https://doi.org/10.1016/j.trsl.2016.04.007CrossRefPubMed

17.

Allison M, Dawson K, Mayberry W, Foss JJAom (1985) Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol 141(1):1–7. https://doi.org/10.1007/bf00446731CrossRefPubMed

18.

Tavasoli S, Alebouyeh M, Naji M, Shakiba Majd G, Shabani Nashtaei M, Broumandnia N et al (2020) Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study. BJU Int 125(1):133–143. https://doi.org/10.1111/bju.14840CrossRefPubMed

19.

Chen F, Bao X, Liu S, Ye K, Xiang S, Yu L et al (2021) Gut microbiota affect the formation of calcium oxalate renal calculi caused by high daily tea consumption. Appl Microbiol Biotechnol 105(2):789–802. https://doi.org/10.1007/s00253-020-11086-wCrossRefPubMed

20.

Ahluwalia N, Dwyer J, Terry A, Moshfegh A, Johnson CJAin (2016) Update on NHANES dietary data: focus on collection, release, analytical considerations, and uses to inform public policy. Adv Nutr 7(1):121–134. https://doi.org/10.3945/an.115.009258CrossRefPubMedPubMedCentral

21.

Yuan C, Jin X, He Y, Liu Y, Xiang L, Wang K (2022) Association of dietary patterns with gut microbiota in kidney stone and non-kidney stone individuals. Urolithiasis 50(4):389–399. https://doi.org/10.1007/s00240-022-01325-2CrossRefPubMed

22.

Mayasari NR, Bai CH, Hu TY, Chao JC, Chen YC, Huang YL et al (2021) Associations of food and nutrient intake with serum hepcidin and the risk of gestational iron-deficiency anemia among pregnant women: a population-based study. Nutrients. https://doi.org/10.3390/nu13103501CrossRefPubMedPubMedCentral

23.

Wang K, Ge J, Han W, Wang D, Zhao Y, Shen Y et al (2022) Risk factors for kidney stone disease recurrence: a comprehensive meta-analysis. BMC Urol 22(1):62. https://doi.org/10.1186/s12894-022-01017-4CrossRefPubMedPubMedCentral

24.

Liu N, Feng Y, Li J, Ma X, Ma F (2022) Relationship between the dietary inflammatory index and kidney stone prevalence. World J Urol 40(6):1545–1552. https://doi.org/10.1007/s00345-022-03998-1CrossRefPubMed

25.

Zhao Y, Fan Y, Wang M, Yu C, Zhou M, Jiang D et al (2021) Kidney stone disease and cardiovascular events: a study on bidirectional causality based on mendelian randomization. Transl Androl Urol 10(12):4344–4352. https://doi.org/10.21037/tau-21-899CrossRefPubMedPubMedCentral

26.

Chang CW, Ke HL, Lee JI, Lee YC, Jhan JH, Wang HS et al (2021) Metabolic syndrome increases the risk of kidney stone disease: a cross-sectional and longitudinal cohort study. J Pers Med. https://doi.org/10.3390/jpm11111154CrossRefPubMedPubMedCentral

27.

Tastemur S, Senel S, Olcucuoglu E, Uzun E (2022) Evaluation of the relationship between fat volume and nephrolithiasis. Curr Med Imaging 18(4):398–403. https://doi.org/10.2174/1573405617666211130154127CrossRefPubMed

28.

Kang HW, Lee SK, Kim WT, Kim YJ, Yun SJ, Lee SC et al (2014) Hypertriglyceridemia and low high-density lipoprotein cholesterolemia are associated with increased hazard for urolithiasis. J Endourol 28(8):1001–1005. https://doi.org/10.1089/end.2014.0135CrossRefPubMed

29.

Masterson JH, Woo JR, Chang DC, Chi T, L’Esperance JO, Stoller ML et al (2015) Dyslipidemia is associated with an increased risk of nephrolithiasis. Urolithiasis 43(1):49–53. https://doi.org/10.1007/s00240-014-0719-3CrossRefPubMed

30.

Berkemeyer S, Bhargava A, Bhargava U (2007) Urinary phosphorus rather than urinary calcium possibly increases renal stone formation in a sample of Asian Indian, male stone-formers. Br J Nutr 98(6):1224–1228. https://doi.org/10.1017/S0007114507778686CrossRefPubMed

31.

Kanbay M, Onal EM, Afsar B, Dagel T, Yerlikaya A, Covic A et al (2018) The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus. Int Urol Nephrol 50(8):1453–1466. https://doi.org/10.1007/s11255-018-1873-2CrossRefPubMed

32.

Rukavina Mikusic NL, Kouyoumdzian NM, Choi MR (2020) Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis. Pflugers Arch 472(3):303–320. https://doi.org/10.1007/s00424-020-02352-xCrossRefPubMed

33.

Ivanovski O, Drueke TB (2013) A new era in the treatment of calcium oxalate stones? Kidney Int 83(6):998–1000. https://doi.org/10.1038/ki.2013.41CrossRefPubMed

34.

Arvans D, Jung YC, Antonopoulos D, Koval J, Granja I, Bashir M et al (2017) Oxalobacter formigenes-derived bioactive factors stimulate oxalate transport by intestinal epithelial cells. J Am Soc Nephrol 28(3):876–887. https://doi.org/10.1681/ASN.2016020132CrossRefPubMed

35.

Pebenito AM, Liu M, Nazzal L, Blaser MJ (2019) Development of a humanized murine model for the study of oxalobacter formigenes intestinal colonization. J Infect Dis 220(11):1848–1858. https://doi.org/10.1093/infdis/jiz370CrossRefPubMedPubMedCentral

36.

Miller AW, Choy D, Penniston KL, Lange D (2019) Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis. Kidney Int 96(1):180–188. https://doi.org/10.1016/j.kint.2019.02.012CrossRefPubMedPubMedCentral

37.

Ticinesi A, Milani C, Guerra A, Allegri F, Lauretani F, Nouvenne A et al (2018) Understanding the gut-kidney axis in nephrolithiasis: an analysis of the gut microbiota composition and functionality of stone formers. Gut 67(12):2097–2106. https://doi.org/10.1136/gutjnl-2017-315734CrossRefPubMed

38.

Tang R, Jiang Y, Tan A, Ye J, Xian X, Xie Y et al (2018) 16S rRNA gene sequencing reveals altered composition of gut microbiota in individuals with kidney stones. Urolithiasis 46(6):503–514. https://doi.org/10.1007/s00240-018-1037-yCrossRefPubMed

39.

Kachroo N, Lange D, Penniston KL, Stern J, Tasian G, Bajic P et al (2021) Meta-analysis of clinical microbiome studies in urolithiasis reveal age, stone composition, and study location as the predominant factors in urolithiasis-associated microbiome composition. mBio 12(4):e0200721. https://doi.org/10.1128/mBio.02007-21CrossRefPubMed

40.

Denburg MR, Koepsell K, Lee JJ, Gerber J, Bittinger K, Tasian GE (2020) Perturbations of the gut microbiome and metabolome in children with calcium oxalate kidney stone disease. J Am Soc Nephrol 31(6):1358–1369. https://doi.org/10.1681/ASN.2019101131CrossRefPubMedPubMedCentral

41.

Ticinesi A, Nouvenne A, Chiussi G, Castaldo G, Guerra A, Meschi T (2020) Calcium oxalate nephrolithiasis and gut microbiota: not just a gut-kidney axis. A nutritional perspective. Nutrients. https://doi.org/10.3390/nu12020548CrossRefPubMedPubMedCentral

42.

Shen W, Sun J, Li Z, Yao F, Lin K, Jiao X (2021) Food intake and its effect on the species and abundance of intestinal flora in colorectal cancer and healthy individuals. Korean J Intern Med 36(3):568–583. https://doi.org/10.3904/kjim.2019.373CrossRefPubMed

43.

Wilck N, Matus MG, Kearney SM, Olesen SW, Forslund K, Bartolomaeus H et al (2017) Salt-responsive gut commensal modulates T(H)17 axis and disease. Nature 551(7682):585–589. https://doi.org/10.1038/nature24628CrossRefPubMedPubMedCentral

44.

Chung WS, Walker AW, Louis P, Parkhill J, Vermeiren J, Bosscher D et al (2016) Modulation of the human gut microbiota by dietary fibres occurs at the species level. BMC Biol 14:3. https://doi.org/10.1186/s12915-015-0224-3CrossRefPubMedPubMedCentral

45.

Sanchez-Tapia M, Hernandez-Velazquez I, Pichardo-Ontiveros E, Granados-Portillo O, Galvez A, Tovar AR et al (2020) Consumption of cooked black beans stimulates a cluster of some clostridia class bacteria decreasing inflammatory response and improving insulin sensitivity. Nutrients. https://doi.org/10.3390/nu12041182CrossRefPubMedPubMedCentral

46.

Scholz-Ahrens KE, Schrezenmeir J (2007) Inulin and oligofructose and mineral metabolism: the evidence from animal trials. J Nutr 137(11 Suppl):2513S-2523S. https://doi.org/10.1093/jn/137.11.2513SCrossRefPubMed

47.

Blaut M, Clavel T (2007) Metabolic diversity of the intestinal microbiota: implications for health and disease. J Nutr 137(3 Suppl 2):751S-755S. https://doi.org/10.1093/jn/137.3.751SCrossRefPubMed

48.

Guo S, Nighot M, Al-Sadi R, Alhmoud T, Nighot P, Ma TY (2015) Lipopolysaccharide regulation of intestinal tight junction permeability is mediated by TLR4 signal transduction pathway activation of FAK and MyD88. J Immunol 195(10):4999–5010. https://doi.org/10.4049/jimmunol.1402598CrossRefPubMed

49.

Amimanan P, Tavichakorntrakool R, Fong-Ngern K, Sribenjalux P, Lulitanond A, Prasongwatana V et al (2017) Elongation factor Tu on Escherichia coli isolated from urine of kidney stone patients promotes calcium oxalate crystal growth and aggregation. Sci Rep 7(1):2953. https://doi.org/10.1038/s41598-017-03213-xCrossRefPubMedPubMedCentral

50.

Carrasco SE, Yang Y, Troxell B, Yang X, Pal U, Yang XF (2015) Borrelia burgdorferi elongation factor EF-Tu is an immunogenic protein during Lyme borreliosis. Emerg Microbes Infect 4(9):e54. https://doi.org/10.1038/emi.2015.54CrossRefPubMedPubMedCentral

51.

Lee HR, Jun HK, Kim HD, Lee SH, Choi BK (2012) Fusobacterium nucleatum GroEL induces risk factors of atherosclerosis in human microvascular endothelial cells and ApoE(-/-) mice. Mol Oral Microbiol 27(2):109–123. https://doi.org/10.1111/j.2041-1014.2011.00636.xCrossRefPubMed

52.

Liu H, Hong XL, Sun TT, Huang XW, Wang JL, Xiong H (2020) Fusobacterium nucleatum exacerbates colitis by damaging epithelial barriers and inducing aberrant inflammation. J Dig Dis 21(7):385–398. https://doi.org/10.1111/1751-2980.12909CrossRefPubMed

53.

Al-Hebshi NN, Nasher AT, Maryoud MY, Homeida HE, Chen T, Idris AM et al (2017) Inflammatory bacteriome featuring Fusobacterium nucleatum and Pseudomonas aeruginosa identified in association with oral squamous cell carcinoma. Sci Rep 7(1):1834. https://doi.org/10.1038/s41598-017-02079-3CrossRefPubMedPubMedCentral

54.

Liu Y, Baba Y, Ishimoto T, Iwatsuki M, Hiyoshi Y, Miyamoto Y et al (2019) Progress in characterizing the linkage between Fusobacterium nucleatum and gastrointestinal cancer. J Gastroenterol 54(1):33–41. https://doi.org/10.1007/s00535-018-1512-9CrossRefPubMed

55.

Cao C, Fan B, Zhu J, Zhu N, Cao JY, Yang DR (2022) Association of gut microbiota and biochemical features in a chinese population with renal uric acid stone. Front Pharmacol 13:888883. https://doi.org/10.3389/fphar.2022.888883CrossRefPubMedPubMedCentral

56.

Liu L, Liang L, Liang H, Wang M, Lu B, Xue M et al (2019) Fusobacterium nucleatum aggravates the progression of colitis by regulating M1 macrophage polarization via AKT2 pathway. Front Immunol 10:1324. https://doi.org/10.3389/fimmu.2019.01324CrossRefPubMedPubMedCentral

57.

Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller LT et al (2020) The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science 368(6494):973–980. https://doi.org/10.1126/science.aay9189CrossRefPubMedPubMedCentral

58.

Aschard H, Laville V, Tchetgen ET, Knights D, Imhann F, Seksik P et al (2019) Genetic effects on the commensal microbiota in inflammatory bowel disease patients. PLoS Genet 15(3):e1008018. https://doi.org/10.1371/journal.pgen.1008018CrossRefPubMedPubMedCentral

59.

Graessler J, Qin Y, Zhong H, Zhang J, Licinio J, Wong ML et al (2013) Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. Pharmacogenom J 13(6):514–522. https://doi.org/10.1038/tpj.2012.43CrossRef

60.

Martin R, Miquel S, Chain F, Natividad JM, Jury J, Lu J et al (2015) Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model. BMC Microbiol 15:67. https://doi.org/10.1186/s12866-015-0400-1CrossRefPubMedPubMedCentral

61.

Duvallet C, Gibbons SM, Gurry T, Irizarry RA, Alm EJ (2017) Meta-analysis of gut microbiome studies identifies disease-specific and shared responses. Nat Commun 8(1):1784. https://doi.org/10.1038/s41467-017-01973-8CrossRefPubMedPubMedCentral

62.

Pasolli E, Truong DT, Malik F, Waldron L, Segata N (2016) Machine learning meta-analysis of large metagenomic datasets: tools and biological insights. PLoS Comput Biol 12(7):e1004977. https://doi.org/10.1371/journal.pcbi.1004977CrossRefPubMedPubMedCentral

63.

Xiang L, Jin X, Liu Y, Ma Y, Jian Z, Wei Z et al (2022) Prediction of the occurrence of calcium oxalate kidney stones based on clinical and gut microbiota characteristics. World J Urol 40(1):221–227. https://doi.org/10.1007/s00345-021-03801-7CrossRefPubMed

Titel: The altered composition of gut microbiota and biochemical features as well as dietary patterns in a southern Chinese population with recurrent renal calcium oxalate stones
verfasst von: Cheng Cao
Xiaohua Jin
Qi Ding
Jin Zhu
Dongrong Yang
Bo Fan
Publikationsdatum: 01.12.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Urolithiasis / Ausgabe 1/2023
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI: https://doi.org/10.1007/s00240-023-01467-x

Neu im Fachgebiet Urologie

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Optimal dual-energy computed tomography scan parameters to detect small-sized urinary stones and their composition

Haplotype of CaSR gene is associated with risk of renal stone disease in West Indian population

Correction to: Effect of a high-citrate beverage on urine chemistry in patients with calcium kidney stones

Correction to: Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4)